Last edition
News about "Neopharmed for Plasil"
Lupin Inks Exclusive Licensing Deal with Neopharmed for Plasil in Brazil and Philippines
Global pharmaceutical major Lupin Limited said its subsidiaries in the Philippines, Multicare Pharmaceuticals, and in Brazil, MedQuimica, have entered into an exclusive licensing agreement with Italy-based Neopharmed Gentili S.p.A. to market and promote the gastroenterology brand Plasil (metoclopramide) in their respective markets.
Neopharmed For Plasil | 19/12/2025 | By Darshana | 175
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy